BR0111193A - Nova forma amorfa de hidrocloreto de sertralina e processo de preparação da mesma. - Google Patents
Nova forma amorfa de hidrocloreto de sertralina e processo de preparação da mesma.Info
- Publication number
- BR0111193A BR0111193A BR0111193-0A BR0111193A BR0111193A BR 0111193 A BR0111193 A BR 0111193A BR 0111193 A BR0111193 A BR 0111193A BR 0111193 A BR0111193 A BR 0111193A
- Authority
- BR
- Brazil
- Prior art keywords
- preparation process
- amorphous form
- sertraline hydrochloride
- new amorphous
- new
- Prior art date
Links
- GLQPTZAAUROJMO-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)benzaldehyde Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC=C(C=O)C=C1 GLQPTZAAUROJMO-UHFFFAOYSA-N 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 229960003660 sertraline hydrochloride Drugs 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229960002073 sertraline Drugs 0.000 abstract 1
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
- C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN540DE2000 IN192343B (enExample) | 2000-05-26 | 2000-05-26 | |
| PCT/IB2001/000909 WO2001090049A1 (en) | 2000-05-26 | 2001-05-24 | Novel amorphous form of sertraline hydrochloride |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0111193A true BR0111193A (pt) | 2003-07-29 |
Family
ID=11097055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0111193-0A BR0111193A (pt) | 2000-05-26 | 2001-05-24 | Nova forma amorfa de hidrocloreto de sertralina e processo de preparação da mesma. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20040063792A1 (enExample) |
| EP (1) | EP1289928A4 (enExample) |
| JP (1) | JP2003534310A (enExample) |
| CN (1) | CN1438989A (enExample) |
| AU (1) | AU2001256595A1 (enExample) |
| BR (1) | BR0111193A (enExample) |
| CA (1) | CA2409856A1 (enExample) |
| CZ (1) | CZ20023903A3 (enExample) |
| IN (1) | IN192343B (enExample) |
| SK (1) | SK17272002A3 (enExample) |
| WO (1) | WO2001090049A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6500987B1 (en) | 1998-11-27 | 2002-12-31 | Teva Pharmaceutical Industries Ltd. | Sertraline hydrochloride polymorphs |
| US6495721B1 (en) | 1999-08-09 | 2002-12-17 | Teva Pharmaceutical Industries Ltd. | Sertraline hydrochloride Form II and methods for the preparation thereof |
| YU47902A (sh) | 1999-12-21 | 2005-11-28 | Teva Pharmaceutical Industries Ltd. | Novi polimorfi sertralin hidrohlorida, postupci za njihovo dobijanje, preparati koji ih sadrže i postupci za njihovu upotrebu |
| US7067700B2 (en) | 2001-05-31 | 2006-06-27 | Fermion Oy | Process for preparing sertraline hydrochloride polymorphic form II |
| EP1499581A1 (en) | 2002-04-29 | 2005-01-26 | Teva Pharmaceutical Industries Ltd. | Process for preparation of polymorphic form ii of sertraline hydrochloride, pharmaceutical formulations and methods of administration thereof |
| JP2007502329A (ja) | 2003-05-23 | 2007-02-08 | トランスフォーム・ファーマシューティカルズ・インコーポレイテッド | セルトラリン組成物 |
| US7173153B2 (en) * | 2003-07-15 | 2007-02-06 | Recordati Industria Chimica E. Farmaceutica S.P.A. | Sertraline hydrochloride form II and methods for the preparation thereof |
| EP1648854A1 (en) | 2003-07-15 | 2006-04-26 | RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.a. | Methods for preparing sertraline hydrochloride polymorphs |
| US20060270859A1 (en) * | 2005-01-27 | 2006-11-30 | Santiago Ini | Duloxetine HCl polymorphs |
| US8158152B2 (en) * | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
| DE102008039271A1 (de) * | 2007-12-23 | 2009-06-25 | Euromed Sa | Neuer Mariendistelextrakt, Verfahren zur Herstellung und Verwendung |
| PL2665363T3 (pl) * | 2011-01-21 | 2020-07-27 | Avery Dennison Corporation | Klej zawierający glukonian chlorheksydyny |
| WO2012158483A2 (en) | 2011-05-16 | 2012-11-22 | Avery Dennison Corporation | Adhesive containing microparticles |
| EP2954019B1 (en) | 2013-02-07 | 2018-08-15 | Avery Dennison Corporation | Antimicrobial adhesives having improved properties |
| US11213432B2 (en) | 2013-03-15 | 2022-01-04 | Avery Dennison Corporation | Transparent cover dressing application system and inclusion of label strip |
| US11337940B2 (en) | 2014-06-05 | 2022-05-24 | Avery Dennison Corporation | Articles with active agent concentrated at the substrate contacting surface and related methods |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4536518A (en) * | 1979-11-01 | 1985-08-20 | Pfizer Inc. | Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine |
| US5166437A (en) * | 1989-03-03 | 1992-11-24 | Orion-Yhtyma Oy | Process for the preparation of fluoxetine |
| US5248699A (en) * | 1992-08-13 | 1993-09-28 | Pfizer Inc. | Sertraline polymorph |
| US5734083A (en) * | 1996-05-17 | 1998-03-31 | Torcan Chemical Ltd. | Sertraline polymorph |
| JP2000026378A (ja) * | 1998-07-03 | 2000-01-25 | Sumika Fine Chemicals Co Ltd | 塩酸セルトラリンの製法 |
| IL143311A0 (en) * | 1998-11-27 | 2002-04-21 | Teva Pharma | Sertraline hydrochloride polymorphs |
| US6500987B1 (en) * | 1998-11-27 | 2002-12-31 | Teva Pharmaceutical Industries Ltd. | Sertraline hydrochloride polymorphs |
| TWI260315B (en) * | 1999-10-29 | 2006-08-21 | Ciba Sc Holding Ag | Polymorphic forms of sertraline hydrochloride |
-
2000
- 2000-05-26 IN IN540DE2000 patent/IN192343B/en unknown
-
2001
- 2001-05-24 US US10/296,455 patent/US20040063792A1/en not_active Abandoned
- 2001-05-24 CN CN01812018A patent/CN1438989A/zh active Pending
- 2001-05-24 AU AU2001256595A patent/AU2001256595A1/en not_active Abandoned
- 2001-05-24 BR BR0111193-0A patent/BR0111193A/pt not_active Application Discontinuation
- 2001-05-24 SK SK1727-2002A patent/SK17272002A3/sk unknown
- 2001-05-24 WO PCT/IB2001/000909 patent/WO2001090049A1/en not_active Ceased
- 2001-05-24 CZ CZ20023903A patent/CZ20023903A3/cs unknown
- 2001-05-24 CA CA002409856A patent/CA2409856A1/en not_active Abandoned
- 2001-05-24 EP EP01929918A patent/EP1289928A4/en not_active Withdrawn
- 2001-05-24 JP JP2001586239A patent/JP2003534310A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2409856A1 (en) | 2001-11-29 |
| AU2001256595A1 (en) | 2001-12-03 |
| CN1438989A (zh) | 2003-08-27 |
| JP2003534310A (ja) | 2003-11-18 |
| IN192343B (enExample) | 2004-04-10 |
| WO2001090049A1 (en) | 2001-11-29 |
| EP1289928A1 (en) | 2003-03-12 |
| US20040063792A1 (en) | 2004-04-01 |
| EP1289928A4 (en) | 2005-06-08 |
| SK17272002A3 (sk) | 2003-05-02 |
| CZ20023903A3 (cs) | 2003-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0115482A (pt) | Composição de sacralose melhorada e processo para sua preparação | |
| PT1303478E (pt) | Processo para a preparacao de alcanoilamidas substituidas | |
| BR0114316A (pt) | Processo para a preparação de formulações em pó | |
| BR0307529A (pt) | Derivados de n-fenil-2-pirimidina-amina | |
| BRPI0502382A (pt) | processo para a preparação de artigos moldados de poliuretano | |
| BRPI0316438C1 (pt) | uso de eritropoietina em doenças cardíacas | |
| BR0209845A (pt) | Formas de dosagem de oxcarbazepina e processo para a preparação das mesmas | |
| BR0311242A (pt) | Processo para preparar modafinil | |
| BR0301667A (pt) | Processo para a preparação de polìmeros em emulsão com pureza elevada | |
| BR0112018B1 (pt) | processo para preparar uma composiÇço para o tratamento de tecido. | |
| PT1147075E (pt) | Processo para a preparacao de cloridrato de l-fenilefrina | |
| PT1272489E (pt) | Processo para a preparacao da forma i cristalina de cabergolina | |
| PT1345939E (pt) | Processo para a preparacao de imidazotriazinonas substituidas por sulfonamida | |
| EP1289928A4 (en) | NEW AMORPHOUS FORM OF SERTRALINE HYDROCHLORIDE | |
| PT1313698E (pt) | Processo para a preparacao de fenilacetonitrilos substituidos | |
| BR0212772A (pt) | Processo para a preparação de repaglinida | |
| BRPI0413139A (pt) | processo para a preparação de l-treonina | |
| BR0214742A (pt) | Polimorfo cristalino de cloridrato de venlafaxina e métodos para sua preparação | |
| BR9808642A (pt) | Processo para preparar eprosartan | |
| PT1292586E (pt) | Processo para a preparacao de pirazolopirimidinonas | |
| BRPI0411751A (pt) | processo de polimerização para preparação de | |
| PT1363516E (pt) | Um processo melhorado para a preparacao da sinvastatina | |
| PT1200414E (pt) | Processo para a preparacao de pirimidnas substituidas | |
| BR0214696A (pt) | Monoidrato de cloridrato de venlafaxina e métodos para a preparação do mesmo | |
| BR9808664A (pt) | Processo para preparar eprosartan |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired |